1
EXHIBIT 99.2
Form of Letter to Stockholders
Dear Stockholder:
Effective as of July 21, 2000, La Jolla Pharmaceutical Company and
American Stock Transfer & Trust Company entered into an Amendment to the Rights
Agreement dated December 3, 1998, by and between La Jolla Pharmaceutical Company
and American Stock Transfer & Trust Company. This Amendment eliminated the
concept and powers of the "Continuing Directors" in response to a clarification
of Delaware law by the Delaware Supreme Court, and amended the definition of
"Acquiring Person" to permit State of Wisconsin Investment Board to invest up to
a level of just under 20% beneficial ownership without triggering the Rights
Agreement.
The attached Summary of Rights describes the Rights Agreement, as
amended, in more detail and supersedes any prior Summary of Rights distributed
to you. We urge you to read the attached summary. Thank you for your continued
support of La Jolla Pharmaceutical Company.
Sincerely,
Xxxxxx X. Xxxxx
Chief Executive Officer
